Advances in high-throughput mass spectrometry in drug discovery.
Saved in:
| Title: | Advances in high-throughput mass spectrometry in drug discovery. |
|---|---|
| Authors: | Dueñas ME; Laboratory for Biomedical Mass Spectrometry, Biosciences Institute, Newcastle University, Newcastle-upon-Tyne, UK., Peltier-Heap RE; Discovery Analytical, Screening Profiling and Mechanistic Biology, GSK R&D, Stevenage, UK., Leveridge M; Discovery Analytical, Screening Profiling and Mechanistic Biology, GSK R&D, Stevenage, UK., Annan RS; Discovery Analytical, Screening Profiling and Mechanistic Biology, GSK R&D, Stevenage, UK., Büttner FH; Drug Discovery Sciences, High Throughput Biology, Boehringer Ingelheim Pharma GmbH&CoKG, Biberach, Germany., Trost M; Laboratory for Biomedical Mass Spectrometry, Biosciences Institute, Newcastle University, Newcastle-upon-Tyne, UK. |
| Source: | EMBO molecular medicine [EMBO Mol Med] 2023 Jan 11; Vol. 15 (1), pp. e14850. Date of Electronic Publication: 2022 Dec 14. |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
